A long-used digestive and energy tonic from Chinese herbal medicine, White Atractylodes shows its most credible signals for easing functional digestive complaints and reducing chemotherapy-related digestive side effects. Immune, anti-inflammatory, and metabolic effects remain laboratory-stage. Most human evidence comes from multi-herb formulas, with the most favorable results from lower-quality studies. Safety appears generally good at traditional doses. (Full Review)

Protocol

Dose

6–12 g/day

Dried rhizome, usually within a multi-herb formula; start low (3–6 g) and titrate

Timing

With or after meals

Supports digestion and reduces gastric irritation

Frequency

2–3 split doses

Consistent with the short half-life of the active atractylenolides

Time to effect

Digestive & energy

1–several weeks

Gradual improvement with consistent dosing

Immune & inflammatory

Over weeks

Builds over weeks rather than acting acutely

Benefits

Medium: Digestive & gastrointestinal symptom relief; reduced chemotherapy-related digestive toxicity

Low: Immune modulation; anti-inflammatory & hepatoprotective effects

Speculative: Metabolic & thermogenic effects; longevity-associated cellular pathways; mood, cognitive & gut-brain effects

Contraindications

Known Asteraceae/Compositae allergy (ragweed, chrysanthemum, marigold, daisy)

Marked yin deficiency with heat/dryness

Severe fluid or electrolyte disturbances

Key Interactions

Anticoagulants/antiplatelets (warfarin, clopidogrel, aspirin)

Antidiabetic drugs (metformin, glipizide, insulin)

Loop/thiazide diuretics (furosemide, hydrochlorothiazide)

NSAIDs (ibuprofen, aspirin)

Blood-thinning supplements (fish oil, vitamin E, ginkgo)

Glucose-lowering supplements (berberine, bitter melon)

Risk & Side Effects

Medium: Allergic hypersensitivity; product quality, contamination & species substitution

Low: Gastrointestinal upset and dryness reactions; potential herb–drug interactions

Speculative: Diuretic and electrolyte effects; reproductive and pregnancy uncertainty

Monitoring

Marker	Target	Why
ALT / AST	ALT ~10–26 U/L; AST ~15–26 U/L	Screens the liver, site of atractylenolide metabolism
Fasting glucose	75–90 mg/dL	Detects additive glucose-lowering with antidiabetic agents
HbA1c	< 5.4%	Tracks longer-term glycemic effect with glucose-lowering agents
Sodium, potassium, eGFR	Na 138–142 mmol/L; K 4.0–4.5 mmol/L; eGFR > 90 mL/min/1.73 m²	Monitors fluid/electrolyte and kidney status given the herb's diuretic action
Eosinophils	< 300 cells/µL	Flags allergic/hypersensitivity response in Asteraceae-sensitive individuals
hs-CRP	< 1.0 mg/L	Tracks systemic inflammation, the herb's proposed anti-inflammatory target

Cadence: Baseline before starting; recheck at 4–8 weeks, then every 3–6 months during continued use

Qualitative Assessment

Digestive comfort: reduced bloating, more formed stools, better appetite
Energy and fatigue: steadier daytime energy, less post-exertional or post-meal tiredness
Fluid balance: less puffiness or fluid retention
Overall resilience: fewer minor infections, steadier wellbeing over weeks

Atractylodis Macrocephalae for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment